Reproducible Clinical Reporting Systems: A Workflow-Oriented Extension of TLFQC for Versioned, Traceable, and Codeless Biostatistics Outputs

Authors

  • Claude M. Robles Department of Electrical Engineering and Computer Science, University of Kansas, Lawrence, KS, USA.

Keywords:

clinical reporting, reproducibility, TLFQC, version control, traceability, codeless biostatistics, workflow automation, regulatory compliance, audit trail, FAIR principles

Abstract

The reliability of clinical reporting in biostatistics is increasingly challenged by the complexity of multi-study data integration, regulatory scrutiny, and the need for transparent, reproducible outputs. Traditional approaches rely on manual scripting and ad hoc validation, which introduce fragility and inconsistency across organizational boundaries. This paper proposes a workflow-oriented extension of the TLFQC framework, originally designed for automated and codeless generation of tables, listings, and figures. The extension emphasizes versioning, traceability, and governance as integral components of a reproducible clinical reporting system. By embedding TLFQC within a continuous integration and delivery pipeline, the proposed architecture enables systematic tracking of data provenance, parameter changes, and output evolution across study milestones. The system supports both regulatory submission requirements and internal audit readiness through immutable audit trails and role-based access controls. A codeless interface lowers the barrier for biostatisticians and clinical programmers, reducing reliance on ad hoc R or SAS scripts while maintaining flexibility for complex analytical workflows. Structural trade-offs between flexibility and reproducibility are examined, including the tension between GUI-driven specification and version control of analysis definitions. The paper further explores deployment sustainability, robustness under varying data formats, and fairness implications related to standardization of output representation across diverse therapeutic areas. Policy and governance considerations are discussed in the context of 21st Century Cures Act and FDA guidance on computerized systems. The proposed extension positions TLFQC not merely as a point solution but as a foundational layer for reproducible, auditable, and interoperable clinical reporting infrastructure.

References

1. Peng, R. D. (2011). Reproducible research in computational science. Science, 334(6060), 1226–1227.

2. U.S. Food and Drug Administration. (2003). Guidance for industry: Part 11, electronic records; electronic signatures — scope and application. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application

3. U.S. Food and Drug Administration. (2017). Use of electronic health record data in clinical investigations: Guidance for industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-electronic-health-record-data-clinical-investigations

4. Gentleman, R., & Temple Lang, D. (2007). Statistical analyses and reproducible research. Journal of Computational and Graphical Statistics, 16(1), 1–23.

5. Stodden, V., Leisch, F., & Peng, R. D. (Eds.). (2014). Implementing reproducible research. CRC Press.

6. Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., ... & Mons, B. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data, 3(1), 160018.

7. Davidson, S. B., & Freire, J. (2008). Provenance and scientific workflows: Challenges and opportunities. Proceedings of the 2008 ACM SIGMOD International Conference on Management of Data, 1345–1350.

8. Boettiger, C. (2015). An introduction to Docker for reproducible research. ACM SIGOPS Operating Systems Review, 49(1), 71–79.

9. Koop, D., Santos, E., & Freire, J. (2008). Provenance-enabled data exploration and visualization with VisTrails. Proceedings of the 16th International Conference on Scientific and Statistical Database Management, 223–240.

10. Beaulieu-Jones, B. K., & Greene, C. S. (2017). Reproducibility of computational workflows is automated using continuous analysis. Nature Biotechnology, 35(4), 342–346.

11. Crowe, B. J., Xia, H. A., Berlin, J. A., Watson, D. J., Shi, H., Lin, S. L., ... & Wang, Y. (2009). Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: A report of the safety planning, evaluation, and reporting team. Clinical Trials, 6(5), 430–440.

12. Vaziri, M., Mandel, L., & Shinnar, A. (2018). Secure data provenance in a clinical trial setting. Journal of the American Medical Informatics Association, 25(6), 651–659.

13. Cito, J., Leitner, P., & Gall, H. C. (2015). The role of dependency management and reproducibility in software engineering. Proceedings of the 2015 IEEE/ACM 12th Working Conference on Mining Software Repositories, 412–415.

14. Holmes, S., & Huber, W. (2019). Modern statistics for modern biology. Cambridge University Press.

15. Patil, P., Peng, R. D., & Leek, J. T. (2016). A statistical definition for reproducibility and replicability. bioRxiv, 066803.

16. Hüllermeier, E., & Kruse, R. (2019). From machine learning to explainable AI. Informatik Spektrum, 42(5), 332–341.

17. Hendler, J. (2014). Data integration for heterogeneous biomedical datasets. Journal of Biomedical Informatics, 47, 1–3.

18. Ling, C., & Wang, Y. (2025). TLFQC: A High-compatible R Shiny based Platform for Automated and Codeless TLFs Generation and Validation. In PharmaSUG 2025 conference proceedings.

19. U.S. Food and Drug Administration. (2016). 21st Century Cures Act. Public Law 114-255.

20. Poldrack, R. A., & Poline, J. B. (2019). The publication and reproducibility challenges of neuroimaging. Nature Reviews Neuroscience, 20(8), 478–489.

Downloads

Published

2025-03-15

How to Cite

Claude M. Robles. (2025). Reproducible Clinical Reporting Systems: A Workflow-Oriented Extension of TLFQC for Versioned, Traceable, and Codeless Biostatistics Outputs. Computer Science and Engineering Transactions, 3(1). Retrieved from https://csetx.org/index.php/cset/article/view/172